Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases

Figure 4 Immunoreactivity of hepatocyte nuclear factor 4alpha isoforms in cirrhotic and hepatocellular carcinoma livers. Data are presented as the mean ± standard error (n=4 tissue sections from 24 paraffin embedded tissue blocks). Data were evaluated for stastistical significance by one-way analysis of variance and are represented as follows: ^aP<0.05, ^bP<0.001as compared to normal for P1/P2 HNF4α (A) and P1- HNF4α (B). Black bar (CA) = Caucasian Americans; Gray bar (AA) = African Americans, as published in[27]